edenbiodesign.com Report : Visit Site

Technical data of the edenbiodesign.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host edenbiodesign.com. Currently, hosted in United States and its service provider is Prolexic Technologies Inc. .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/10.0 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home < home investors < investors news < news investor faqs < investor faqs analysts coverage < analysts coverage stock information < stock information m&a; activities < m&a; activities corporate governance < corporate governance shareholder services < shareholder services financial information < financial information products < products what we treat < what we treat key products < key products drug safety < drug safety quality < quality patent notices < patent notices medical information < medical information r & d < r & d we live open science < we live open science r&d; areas of focus < r&d; areas of focus clinical trials < clinical trials pre-approval access < pre-approval access about < about company profile < company profile executive leadership < executive leadership global footprint < global footprint global locations < global locations contact < contact news < news press releases < press releases media contacts < media contacts newsroom < newsroom careers < careers career opportunities < career opportunities working at allergan < working at allergan our employees < our employees fellowship program < fellowship program responsibility < responsibility social contract < social contract social responsibility < social responsibility allergan foundation < allergan foundation california supply chain disclosure < california supply chain disclosure alliance support and ime grants < alliance support and ime grants health care provider partnerships & payments < health care provider partnerships & payments patient resources < patient resources patient safety & product quality < patient safety & product quality physician resources < physician resources animal testing < animal testing home investors products r & d about news careers responsibility search home > investors > read the full story> allergan acquisition: investor information news events & presentations investor faqs analysts coverage stock information stock chart & quote historical price lookup investment calculator preferred shares m&a; activities allergan acquisition forest laboratories acquisition warner chilcott acquisition teva agreement corporate governance executive officers and directors committee composition committee charters code of conduct governance guidelines insider transactions allergan compliance program memorandum of association shareholder services information requests investor kit e-mail alerts dividends financial information sec filings annual reports quarterly results proxy materials corporate fact sheet products > what we treat key products our products product prescribing drug safety quality patent notices medical information medical information request r & d > we live open science r&d; areas of focus allergan pipeline advancing the pipeline clinical trials participating in an allergan clinical trial clinical trial results sharing post marketing commitments sharing patient-level data clinical trials investigators investigator initiated trials pre-approval access about > company profile executive leadership global footprint pharmaceuticals business development global locations commercial operations supply chain countries contact news > ceo blog press releases media contacts newsroom allergan images allergan logos company profile executive bios & photos careers > career opportunities working at allergan our employees albert yao caitlin sandahl angela hodge jose miguel herrera shuyan li christine birchnall fellowship program responsibility > learn more> high priorities: sustainability & continual improvement social contract social responsibility community sustainability environmental employees partners public policy allergan foundation california supply chain disclosure alliance support and ime grants alliance support independent medical education grants health care provider partnerships & payments affordable care act patient resources patient assistance programs patient safety & product quality research and development risks and benefits quality physician resources animal testing >go! our employees i am bold for life: albert yao read more news 07.10.2018 | investors allergan expands refresh® portfolio with new refresh® repair ... 06.28.2018 | investors allergan's study in chronic migraine receives migraine ... see all news > q1 2018 earnings pdfs for download q1 2018 earnings release > q1 2018 earnings deck (pdf) stock quote refresh quote exchange volume country websites global corporate website africa egypt south africa americas argentina barbados bolivia brazil canada chile colombia costa rica dominican republic ecuador el salvador guatemala honduras jamaica mexico panama peru puerto rico trinidad & tobago uruguay venezuela asia pacific australia bahrain bangladesh china hong kong india indonesia isreal japan jordan korea kuwait lebanon malaysia new zealand pakistan palestine philippines saudi arabia singapore sri lanka taiwan thailand united arab emirates vietnam europe austria belgium bulgaria czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania malta netherlands norway poland portugal romania russia serbia slovakia spain sweden switzerland turkey ukraine united kingdom global compliance terms privacy sitemap © allergan 2018 website cookie consent allergan’s websites may ask your browser to store cookies, a small piece of data, on your computer or mobile device. a cookie can be used to enable a site to remember information that you previously input. it also helps deliver content-specific information to you and tracks how sections of websites are used. we may also use cookies to understand your preferences and tailor your access to your preferences. your consent is required for allergan to remember your user details and preferences over time. if you consent, check “i accept.” you can withdraw your consent by changing your browser settings to erase cookies from your computer’s hard drive, block all cookies, or receive a warning before a cookie is stored. please check your internet browser’s instructions to learn more about these functions. your consent is voluntary; however, if you do not consent to cookies being installed on your browser, allergan may not be able to provide you full access to or all the functionality of our websites. by checking "i accept," i authorize allergan, or any contracted third parties acting on its behalf, to install cookies on my browser to remember the information that i input, track how i use sections of websites, enable allergan to remember my user custom preferences, and to tailor my access to the website per my preferences. i accept close window

URL analysis for edenbiodesign.com

http://www.allergan.com/about/global-locations/countries/ukraine
https://www.allergan.com/home/responsibility/alliance-support-and-ime-grants/independent-medical-education-grants
https://www.allergan.com/home/products/drug-safety
http://www.allergan.com/about/global-locations/countries/malaysia
http://www.allergan.com/about/global-locations/countries/turkey
https://www.allergan.com/home/investors/corporate-governance/insider-transactions
https://www.allergan.com/home/investors/m-a-activities
https://www.allergan.com/home/careers/career-opportunities
https://www.allergan.com/home/products
https://www.allergan.com/home/responsibility/social-contract
https://www.allergan.com/home/about/company-profile
https://www.allergan.com/home/investors/shareholder-services/investor-kit
https://www.allergan.com/home/investors/corporate-governance/committee-charters
https://www.allergan.com/home/investors/stock-information/investment-calculator
https://www.allergan.com/home/about/global-locations/countries

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: edenbiodesign.com
Registry Domain ID: 96708592_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2017-02-21T13:01:06-0800
Creation Date: 2003-04-11T03:14:13-0700
Registrar Registration Expiration Date: 2018-04-11T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID:
Registrant Name: Domain Administrator
Registrant Organization: Allergan, Inc.
Registrant Street: 2525 Dupont Drive,
Registrant City: Irvine
Registrant State/Province: CA
Registrant Postal Code: 92612
Registrant Country: US
Registrant Phone: +1.7142466799
Registrant Phone Ext:
Registrant Fax: +1.7142462418
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Administrator
Admin Organization: Allergan, Inc.
Admin Street: 2525 Dupont Drive,
Admin City: Irvine
Admin State/Province: CA
Admin Postal Code: 92612
Admin Country: US
Admin Phone: +1.7142466799
Admin Phone Ext:
Admin Fax: +1.7142462418
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Domain Administrator
Tech Organization: Allergan, Inc.
Tech Street: 2525 Dupont Drive,
Tech City: Irvine
Tech State/Province: CA
Tech Postal Code: 92612
Tech Country: US
Tech Phone: +1.7142466799
Tech Phone Ext:
Tech Fax: +1.7142462418
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns5.markmonitor.com
Name Server: ns3.markmonitor.com
Name Server: ns2.markmonitor.com
Name Server: ns1.markmonitor.com
Name Server: ns7.markmonitor.com
Name Server: ns4.markmonitor.com
Name Server: ns6.markmonitor.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-09T00:34:25-0700 <<<

The Data in MarkMonitor.com's WHOIS database is provided by MarkMonitor.com for
information purposes, and to assist persons in obtaining information about or
related to a domain name registration record. MarkMonitor.com does not guarantee
its accuracy. By submitting a WHOIS query, you agree that you will use this Data
only for lawful purposes and that, under no circumstances will you use this Data to:
(1) allow, enable, or otherwise support the transmission of mass unsolicited,
commercial advertising or solicitations via e-mail (spam); or
(2) enable high volume, automated, electronic processes that apply to
MarkMonitor.com (or its systems).
MarkMonitor.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.

MarkMonitor is the Global Leader in Online Brand Protection.

MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services

Visit MarkMonitor at http://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220

For more information on Whois status codes, please visit
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en


  REGISTRAR MARKMONITOR INC.

  REFERRER http://www.markmonitor.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =edenbiodesign.com

  PORT 43

  SERVER whois.markmonitor.com

  ARGS edenbiodesign.com

  PORT 43

  TYPE domain

DOMAIN

  NAME edenbiodesign.com

NSERVER

  NS1.MARKMONITOR.COM 64.124.69.50

  NS2.MARKMONITOR.COM 162.88.60.13

  NS3.MARKMONITOR.COM 162.88.61.15

  NS4.MARKMONITOR.COM 162.88.60.15

  NS5.MARKMONITOR.COM 162.88.61.17

  NS6.MARKMONITOR.COM 162.88.60.17

  NS7.MARKMONITOR.COM 162.88.61.19

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2016-10-06

  CREATED 2003-04-11

  EXPIRES 2018-04-11

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .